The amendments to the Food and Drug Act will allow direct-to-consumer advertising of drugs, make it easier for drugs to get to market and more difficult for consumers to find out about ineffective drugs.

We speak about Bill C-51 with Joel Lexchin, an emergency room doctor and professor at York University's School of Health Policy and Management.

To find out more about Redeye, check out our website.